BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Debray D, Rainteau D, Barbu V, Rouahi M, El Mourabit H, Lerondel S, Rey C, Humbert L, Wendum D, Cottart CH. Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies. Gastroenterology. 2012;142:1581-1591.e6. [PMID: 22370478 DOI: 10.1053/j.gastro.2012.02.033] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Slae M, Wilschanski M. Cystic fibrosis and the gut. Frontline Gastroenterol 2021;12:622-8. [PMID: 34917319 DOI: 10.1136/flgastro-2020-101610] [Reference Citation Analysis]
2 Gookin JL, Mathews KG, Cullen J, Seiler G. Qualitative metabolomics profiling of serum and bile from dogs with gallbladder mucocele formation. PLoS One 2018;13:e0191076. [PMID: 29324798 DOI: 10.1371/journal.pone.0191076] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
3 Fiorotto R, Amenduni M, Mariotti V, Cadamuro M, Fabris L, Spirli C, Strazzabosco M. Animal models for cystic fibrosis liver disease (CFLD). Biochim Biophys Acta Mol Basis Dis 2019;1865:965-9. [PMID: 30071276 DOI: 10.1016/j.bbadis.2018.07.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Merlen G, Bidault‐jourdainne V, Kahale N, Glenisson M, Ursic‐bedoya J, Doignon I, Garcin I, Humbert L, Rainteau D, Tordjmann T. Hepatoprotective impact of the bile acid receptor TGR5. Liver Int 2020;40:1005-15. [DOI: 10.1111/liv.14427] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
5 Parisi GF, Mòllica F, Giallongo A, Papale M, Manti S, Leonardi S. Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00308-7] [Reference Citation Analysis]
6 Qi L, Tian Y, Chen Y. Gall bladder: The metabolic orchestrator. Diabetes Metab Res Rev 2019;35:e3140. [PMID: 30770629 DOI: 10.1002/dmrr.3140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Zarei K, Meyerholz DK, Stoltz DA. Early intrahepatic duct defects in a cystic fibrosis porcine model. Physiol Rep 2021;9:e14978. [PMID: 34288572 DOI: 10.14814/phy2.14978] [Reference Citation Analysis]
8 Di Ciaula A, Garruti G, Wang DQ, Portincasa P. Cholecystectomy and risk of metabolic syndrome. Eur J Intern Med 2018;53:3-11. [PMID: 29706426 DOI: 10.1016/j.ejim.2018.04.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
9 Bertolini A, van de Peppel IP, Doktorova-Demmin M, Bodewes FAJA, de Jonge H, Bijvelds M, Verkade HJ, Jonker JW. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol. Am J Physiol Gastrointest Liver Physiol 2019;316:G404-11. [PMID: 30653340 DOI: 10.1152/ajpgi.00188.2018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Boyer JL, Soroka CJ. A cholecystohepatic shunt pathway: does the gallbladder protect the liver? Gastroenterology 2012;142:1416-9. [PMID: 22542828 DOI: 10.1053/j.gastro.2012.04.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
11 Reznikov LR. Cystic Fibrosis and the Nervous System. Chest 2017;151:1147-55. [PMID: 27876591 DOI: 10.1016/j.chest.2016.11.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
12 Sweed N, Kim HJ, Hultenby K, Barros R, Parini P, Sancisi V, Strandvik B, Gabbi C. Liver X receptor β regulates bile volume and the expression of aquaporins and cystic fibrosis transmembrane conductance regulator in the gallbladder. Am J Physiol Gastrointest Liver Physiol 2021;321:G243-51. [PMID: 34259574 DOI: 10.1152/ajpgi.00024.2021] [Reference Citation Analysis]
13 Wang ZC, Zhang N, Chen WG, Zheng Y. Clinical features of cirrhosis with gallstones: Analysis of 105 cases. Shijie Huaren Xiaohua Zazhi 2015; 23(8): 1308-1313 [DOI: 10.11569/wcjd.v23.i8.1308] [Reference Citation Analysis]
14 Bodewes FA, Bijvelds MJ, de Vries W, Baller JF, Gouw AS, de Jonge HR, Verkade HJ. Cholic acid induces a Cftr dependent biliary secretion and liver growth response in mice. PLoS One 2015;10:e0117599. [PMID: 25680200 DOI: 10.1371/journal.pone.0117599] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
15 Poetter-Lang S, Staufer K, Baltzer P, Tamandl D, Muin D, Bastati N, Halilbasic E, Hodge JC, Trauner M, Kazemi-Shirazi L, Ba-Ssalamah A. The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study. Eur Radiol 2019;29:1048-58. [PMID: 30054796 DOI: 10.1007/s00330-018-5650-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
16 Assis DN, Debray D. Gallbladder and bile duct disease in Cystic Fibrosis.J Cyst Fibros. 2017;16 Suppl 2:S62-S69. [PMID: 28986023 DOI: 10.1016/j.jcf.2017.07.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
17 Merlen G, Ursic-Bedoya J, Jourdainne V, Kahale N, Glenisson M, Doignon I, Rainteau D, Tordjmann T. Bile acids and their receptors during liver regeneration: "Dangerous protectors". Mol Aspects Med. 2017;56:25-33. [PMID: 28302491 DOI: 10.1016/j.mam.2017.03.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
18 Bijvelds MJ, de Jonge HR, Verkade HJ. Bile Acid Handling in Cystic Fibrosis: Marked Phenotypic Differences Between Mouse Models. Gastroenterology 2012;143:e19-20. [DOI: 10.1053/j.gastro.2012.08.052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Zhou L, Chen L, Wang Y, Huang J, Yang G, Tan Z, Wang Y, Liao J, Zhou G, Hu K, Li Z, Ouyang D. Impact of NR1I2, adenosine triphosphate-binding cassette transporters genetic polymorphisms on the pharmacokinetics of ginsenoside compound K in healthy Chinese volunteers. J Ginseng Res 2019;43:460-74. [PMID: 31308818 DOI: 10.1016/j.jgr.2018.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
20 Dawson PA, Karpen SJ. Intestinal transport and metabolism of bile acids. J Lipid Res. 2015;56:1085-1099. [PMID: 25210150 DOI: 10.1194/jlr.r054114] [Cited by in Crossref: 216] [Cited by in F6Publishing: 121] [Article Influence: 27.0] [Reference Citation Analysis]
21 Mousa MS, Feldman JC, Mahajan P. Microgallbladder: Self-Remitting Acute Cholecystitis-Like Condition Unique to Patients with Cystic Fibrosis. Case Rep Radiol 2019;2019:6737428. [PMID: 31321111 DOI: 10.1155/2019/6737428] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Woods SE, Leonard MR, Hayden JA, Brophy MB, Bernert KR, Lavoie B, Muthupalani S, Whary MT, Mawe GM, Nolan EM, Carey MC, Fox JG. Impaired cholecystokinin-induced gallbladder emptying incriminated in spontaneous "black" pigment gallstone formation in germfree Swiss Webster mice. Am J Physiol Gastrointest Liver Physiol 2015;308:G335-49. [PMID: 25477375 DOI: 10.1152/ajpgi.00314.2014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
23 Dawson PA. Bile Formation and the Enterohepatic Circulation. Physiology of the Gastrointestinal Tract. Elsevier; 2018. pp. 931-56. [DOI: 10.1016/b978-0-12-809954-4.00041-4] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
24 Housset C, Chrétien Y, Debray D, Chignard N. Functions of the Gallbladder. Compr Physiol 2016;6:1549-77. [PMID: 27347902 DOI: 10.1002/cphy.c150050] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
25 Li L, Somerset S. Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy. Dig Liver Dis 2014;46:865-74. [PMID: 25053610 DOI: 10.1016/j.dld.2014.06.011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
26 Brodlie M, Aseeri A, Lordan JL, Robertson AG, McKean MC, Corris PA, Griffin SM, Manning NJ, Pearson JP, Ward C. Bile acid aspiration in people with cystic fibrosis before and after lung transplantation. Eur Respir J 2015;46:1820-3. [PMID: 26493787 DOI: 10.1183/13993003.00891-2015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
27 Zarei K, Stroik MR, Gansemer ND, Thurman AL, Ostedgaard LS, Ernst SE, Thornell IM, Powers LS, Pezzulo AA, Meyerholz DK, Stoltz DA. Early pathogenesis of cystic fibrosis gallbladder disease in a porcine model. Lab Invest 2020;100:1388-99. [PMID: 32719544 DOI: 10.1038/s41374-020-0474-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Boyer JL. Bile formation and secretion. Compr Physiol. 2013;3:1035-1078. [PMID: 23897680 DOI: 10.1002/cphy.c120027] [Cited by in Crossref: 115] [Cited by in F6Publishing: 196] [Article Influence: 12.8] [Reference Citation Analysis]
29 Humbert L, Rainteau D, Tuvignon N, Wolf C, Seksik P, Laugier R, Carrière F. Postprandial bile acid levels in intestine and plasma reveal altered biliary circulation in chronic pancreatitis patients. Journal of Lipid Research 2018;59:2202-13. [DOI: 10.1194/jlr.m084830] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 2.8] [Reference Citation Analysis]
30 Bidault-Jourdainne V, Merlen G, Glénisson M, Doignon I, Garcin I, Péan N, Boisgard R, Ursic-Bedoya J, Serino M, Ullmer C, Humbert L, Abdelrafee A, Golse N, Vibert E, Duclos-Vallée JC, Rainteau D, Tordjmann T. TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload. JHEP Rep 2021;3:100214. [PMID: 33604531 DOI: 10.1016/j.jhepr.2020.100214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Staufer K, Halilbasic E, Trauner M, Kazemi-Shirazi L. Cystic fibrosis related liver disease--another black box in hepatology. Int J Mol Sci 2014;15:13529-49. [PMID: 25093717 DOI: 10.3390/ijms150813529] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
32 Holter MM, Chirikjian MK, Govani VN, Cummings BP. TGR5 Signaling in Hepatic Metabolic Health. Nutrients 2020;12:E2598. [PMID: 32859104 DOI: 10.3390/nu12092598] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Wang X, Liu W, Zheng T, Park JM, Smith DE, Feng MR. Population pharmacokinetics of mycophenolic acid and its glucuronide metabolite in lung transplant recipients with and without cystic fibrosis. Xenobiotica 2017;47:697-704. [DOI: 10.1080/00498254.2016.1214885] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
34 Fiorotto R, Strazzabosco M. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota. Cell Mol Gastroenterol Hepatol 2019;8:197-207. [PMID: 31075352 DOI: 10.1016/j.jcmgh.2019.04.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
35 Cai JS, Chen JH. The mechanism of enterohepatic circulation in the formation of gallstone disease. J Membr Biol 2014;247:1067-82. [PMID: 25107305 DOI: 10.1007/s00232-014-9715-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
36 Debray D, Corvol H, Housset C. Modifier genes in cystic fibrosis-related liver disease. Curr Opin Gastroenterol 2019;35:88-92. [PMID: 30585791 DOI: 10.1097/MOG.0000000000000508] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 8.5] [Reference Citation Analysis]
37 Portincasa P, Di Ciaula A, Garruti G, Vacca M, De Angelis M, Wang DQ. Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome. Nutrients 2020;12:E3709. [PMID: 33266235 DOI: 10.3390/nu12123709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
38 Olivier AK, Gibson-Corley KN, Meyerholz DK. Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology. Am J Physiol Gastrointest Liver Physiol 2015;308:G459-71. [PMID: 25591863 DOI: 10.1152/ajpgi.00146.2014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
39 Debray D, El Mourabit H, Merabtene F, Brot L, Ulveling D, Chrétien Y, Rainteau D, Moszer I, Wendum D, Sokol H, Housset C. Diet-Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice. Hepatol Commun 2018;2:1533-49. [PMID: 30556040 DOI: 10.1002/hep4.1266] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
40 Firrincieli D, Zúñiga S, Rey C, Wendum D, Lasnier E, Rainteau D, Braescu T, Falguières T, Boissan M, Cadoret A, Housset C, Chignard N. Vitamin D nuclear receptor deficiency promotes cholestatic liver injury by disruption of biliary epithelial cell junctions in mice. Hepatology 2013;58:1401-12. [PMID: 23696511 DOI: 10.1002/hep.26453] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
41 Ikpa PT, Doktorova M, Meijsen KF, Nieuwenhuijze NDA, Verkade HJ, Jonker JW, de Jonge HR, Bijvelds MJC. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice. Cell Mol Gastroenterol Hepatol 2020;9:47-60. [PMID: 31470114 DOI: 10.1016/j.jcmgh.2019.08.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
42 Zhang YM, Xu X, Yu Q, Liu YH, Zhang YH, Chen LX, Liu Y. Reversing the Cytotoxicity of Bile Acids by Supramolecular Encapsulation. J Med Chem 2017;60:3266-74. [PMID: 28398754 DOI: 10.1021/acs.jmedchem.6b01536] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
43 van de Peppel IP, Bodewes FAJA, Verkade HJ, Jonker JW. Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosis. J Cyst Fibros 2019;18:313-20. [PMID: 30201330 DOI: 10.1016/j.jcf.2018.08.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]